布地奈德混悬液雾化吸入治疗急性咽喉炎的疗效探讨

Study on the therapeutic effect of budesonide suspension inhalation in the treatment of acute pharyngitis

目的 探讨急性咽喉炎患者治疗中使用布地奈德混悬液雾化吸入的价值。方法 纳入60例急性咽喉炎患者研究(2019年1月~2021年6月),按双盲法分为对照组(n=30,采用地塞米松治疗)、观察组(n=30,采用布地奈德治疗),统计两组临床疗效、临床症状缓解时间、炎症因子水平。结果 (1)临床疗效:观察组(93.33%)高于对照组(73.33%),组间对比P<0.05。(2)临床症状缓解时间:观察组各症状缓解时间短于对照组,组间对比P<0.05。(3)炎症因子水平:观察组CRP、TNF-α、IL-6低于对照组,组间对比P<0.05。结论布地奈德混悬液雾化吸入在急性咽喉炎治疗中效果确切,值得借鉴及参考。

Objective To explore the value of nebulized inhalation of budesonide suspension in the treatment of patients with acute pharyngitis. Methods A study of 60 patients with acute pharyngitis(January 2019 to June 2021)were enrolled and divided into a control group(n=30, treated with dexamethasone) and an observation group(n=30,treated with dexamethasone) according to the double-blind method. Budesonide treatment, the clinical efficacy, clinical symptom relief time, and inflammatory factor levels were counted in the two groups. Results(1) Short-term curative effect: the observation group(93.33%) was higher than the control group(73.33%), and the comparison between the groups was P<0.05.(2) Clinical symptom remission time: The remission time of each symptom in the observation group was shorter than that in the control group, and the comparison between the groups was P<0.05.(3) Inflammatory factor levels: CRP, TNF-α, and IL-6 in the observation group were lower than those in the control group, and the comparison between groups was P<0.05. Conclusion Aerosol inhalation of budesonide suspension is effective in the treatment of acute pharyngitis, which is worth learning.